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The transcription factors of the Rel/NF-κB family function as key regulators of innate and adoptive immunity. Tightly and
temporally controlled activation of NF-κB-signalling pathways ensures prevention of harmful immune cell dysregulation, whereas
a loss of control leads to pathological conditions such as severe inﬂammation, autoimmune disease, and inﬂammation-associated
oncogenesis. Five family members have been identiﬁed in mammals: RelA (p65), c-Rel, RelB, and the precursor proteins NF-
κB1 (p105) and NF-κB2 (p100), that are processed into p50 and p52, respectively. While RelA-containing dimers are present in
most cell types, c-Rel complexes are predominately found in cells of hematopoietic origin. In T-cell lymphocytes, certain genes
essential for immune function such as Il2 and Foxp3 are directly regulated by c-Rel. Additionally, c-Rel-dependent IL-12 and IL-
23 transcription by macrophages and dendritic cells is crucial for T-cell diﬀerentiation and eﬀector functions. Accordingly, c-Rel
expression in T cells and antigen-presenting cells (APCs) controls a delicate balance between tolerance and immunity. This review
gives a selective overview on recent progress in understanding of diverse roles of c-Rel in regulating adaptive immunity.
1.Introduction
c-Rel is a member of the Rel/NF-κB family of eukaryotic
transcription factors, which also includes the proteins RelA
(p65), RelB, NF-κB1 (p105/p50), and NF-κB2 (p100/p52).
NF-κB transcription factors can form various homo- and
heterodimers possessing unique speciﬁcities in regulating
target gene expression [1]. Despite some redundancy, func-
tional studies on mice lacking one or more NF-κB proteins
revealed that distinct NF-κB subunits play speciﬁc role in
regulating T-cell development and eﬀector functions [2–5].
NF-κB complexes are held in the cytoplasm by interacting
with a family of inhibitory proteins known as the IκB
proteins.Ingeneral,bindingofIκBproteinstoNF-κBdimers
masks the nuclear localization signals of NF-κB proteins
and inhibits both, nuclear import of NF-κBc o m p l e x e sa s
well as binding to their speciﬁc DNA binding site (κB
site) [6]. Activation of NF-κB complexes in T lymphocytes
requires T-cell receptor (TCR) stimulation, which provides a
signal for phosphorylation and degradation of IκB proteins
via the ubiquitin-proteasome system in order to initiate
nuclear translocation and DNA binding of active NF-κB
dimers [7]. In the past decade, several studies have been
conducted to identify genes that are directly regulated by the
transcription factor c-Rel [8–12]. Despite extensive research,
not all c-Rel-controlled genes have been identiﬁed yet. Most
information about the role of c-Rel in T lymphocytes has
come from in vivo analyses of c-Rel deﬁcient mice suggesting
an important function for this protein in regulating T cell
development, diﬀerentiation, and eﬀe c t o rf u n c t i o ni nt h y -
mus and peripheral lymphoid tissues. This review attempts
to highlight various nonredundant physiological functions
of c-Rel, particularly with regard to regulation of T-cell-
mediated immunity.
2. c-Rel-SignallingPathwayinT Lymphocytes
Three main NF-κB activating pathways exist in mammalian
cells [13]. The so-called canonical NF-κBp a t h w a yb yw h i c h
cytokines and other various signals initiate activation of2 Clinical and Developmental Immunology
RelA/p50 and c-Rel/p50 heterodimers has been investigated
in greatest detail. A central component in NF-κB regulation
is a serine-speciﬁc IκB kinase (IKK), a complex composed
of three subunits: IKKα (IKK1), IKKβ (IKK2), and IKKγ
(NEMO). In T lymphocytes, the canonical pathway is
triggered by TCR and CD28 engagement resulting in acti-
vation of IKKα/IKKβ/IKKγ complex. Following stimulation,
activation of IKK results in phosphorylation of IκBs on spe-
ciﬁc serine residues, recruitment of the SCFβ-TrCP ubiquitin
ligase complex, rapid polyubiquitination, and subsequent
degradationofIκBinhibitoryproteinsbythe26Sproteasome
[14]. IκBα is phosphorylated by IKKβ on two N-terminal
serine residues, Ser32 and Ser36, which creates a binding site
for the receptor subunit (β-TrCP) of speciﬁc ubiquitin E3
ligase SCF. Once liberated from IκB molecules, p65/50 and
c-Rel/p50dimersparticipateinthetranscriptionalregulation
of distinct genes involved in adaptive immunity functions. In
contrast,thealternativeNF-κBactivationpathwayisinduced
byasubsetofTNFRfamilymembers(e.g.,LTβRandBAFFR)
involving NIK and IKKα-mediated p100 processing and
generation of transcriptionally active p52/RelB heterodimers
[15, 16]( Figure 1). The major function of this pathway is
related to the development and organization of secondary
lymphoid organs (downstream of LTβR) and homeostasis
of B cells (downstream of BAFFR) [6, 17]. Although T cells
express a number of costimulatory TNFR family members
such as OX40, CD30, and GITR that are assumed to
induce processing of p100 via activation of NIK and IKKα
homodimers [18, 19], it remains largely unclear how the
alternative NF-κB pathway exactly regulates T-cell diﬀerenti-
ation, eﬀector functions, and memory responses. The third
NF-κB pathway, also called p105 pathway, is initiated by
IKKβ through phosphorylation of p105 precursor protein
at Ser927 and Ser932. It uses the same IKK complex as
the canonical pathway and its activation lead to complete
degradation of the p105 molecule and release of docked
molecules [14, 20, 21].
Since the discovery of NF-κB proteins 25 years ago,
there have been many questions with respect to the selec-
tivity and diversity of NF-κB functions. Novel studies have
begun to reveal how the complex networks of positive and
negative regulatory signals and crosstalk between activat-
ing pathways shape the NF-κB response in a cell-type-
dependent and stimulus-speciﬁc way [17, 22–24]. In na¨ ıve
T cells, TCR stimulation and subsequent IKKβ-dependent
phosphorylation of IκBα lead to the nuclear translocation of
active NF-κB dimers. The protein kinase C isozyme PKC-
θ is a central molecule for recruiting additional factors
required for IKK-mediated NF-κB activation in T cells. TCR-
mediated activation of p65/p50 and c-Rel/p50 dimers in
T cells includes activation of kinases of the Src and the
Syk families. Furthermore, CD28 and TCR costimulation
facilitates phosphorylation of CARMA1 and its recruitment
into signalling complex with Bcl10 and MALT1 (CBM
complex, Figure 1). Although not completely elucidated,
mechanisms such as linear ubiquitination of NEMO and
phosphorylation of IKKβ (probably by TAK1) lead to the
activation of the IKK complex and phosphorylation of IκBs
[16]. Cellular localization of NF-κB proteins is controlled
by three IκB isoforms: IκBα,I κBβ and IκBε. Interestingly,
the rate of degradation and resynthesis of each IκBi s o f o r m
may vary in cell-speciﬁc way [25]. Whereas IκBα mediates
rapid NF-κB activation and strong negative feedback loop
regulation, IκBβ and IκBε allow a relatively stable NF-
κB response by responding more slowly and acting to
dampen oscillatory NF-κBa c t i v a t i o np r o ﬁ l e[ 25–27]. An
important question is how the closely related RelA and c-Rel
proteinscanoperatedistinctlyinTlymphocytesandwhether
the inhibitory IκBs play a central role in these processes.
Recent studies suggest that triggering the TCR/CD3 complex
resultsinrapidtranslocationofactivep65-containingdimers
into the nucleus and slower activation of c-Rel complexes.
As consequence, c-Rel-dependent gene transcription in T
cells is slower as compared to p65-mediated responses.
In unstimulated T cells, c-Rel is primarily associated with
IκBβ, and the proportion of c-Rel bound to IκBα can be
substantially increased after activation of cells with TNF-
α and IL-1β [28, 29]. In particular, IκBα is degraded
more rapidly than IκBβ and IκBε. Taken together, in na¨ ıve
T cells, two members of the classical NF-κB activating
pathway, p65 and c-Rel,seem to be diﬀerentially regulated by
forming distinct complexes with IκBs. c-Rel dimers cannot
be easily activated as c-Rel is mainly complexed to IκBβ.
Costimulatory signals transmitted by CD80/86/CD28 and
the presence of proinﬂammatory cytokines secreted by APCs
increase IκBβ degradation and c-Rel is consequently shifted
to IκBα-associated complexes [29].
Remarkably,turnoverofc-Relitselfseemstoberegulated
by the ubiquitin-proteasome pathway adding another level
of the complexity to its regulation [30]. A novel study
has described that the E3 ubiquitin ligase Peli1 mediates
polyubiquitination of c-Rel and subsequent degradation of
this protein by the 26S proteasome. This prevents aberrant
accumulation of c-Rel during T-cell activation. Interestingly,
Peli1 deﬁciency in mice results in nuclear accumulation of c-
Rel, T-cell hyperactivation, and spontaneous development of
autoimmunityassociatedwithmultiorganinﬂammationand
production of autoantibodies [31]. This ﬁnding emphasizes
that regulation of c-Rel expression in T cells might play
an important role in the maintenance of peripheral T-cell
tolerance.
3. Cell-Autonomous Role of c-Rel in
T-Lymphocyte Differentiation
The diﬀerentiation of the CD4+ T-cell lineage into T
eﬀector cells is a crucial prerequisite for a successful host
immune defense against pathogens. Functional specializa-
tion is coordinated by a complex genetic network, initiated
and terminated in a time-dependent manner. Several studies
have attempted to identify transcriptional signatures and
master transcription factors driving the diﬀerentiation of
individual T-cell subsets. Recently, a discovery of huge range
of the functional plasticity and heterogeneity of T-cells has
drawn much attention [32, 33]. As several subpopulations
have only been examined in vitro, it is still unclear if theyClinical and Developmental Immunology 3
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Figure 1: Canonical and alternative NF-κB activation pathways in T cells. Several signals are required for the activation of the canonical
NF-κB-signalling pathway. The inhibitory IκB proteins typically bind to dimers of the NF-κB family such as p65/p50 (not shown in the
ﬁgure) and c-Rel/p50 to generate inactive complexes that are sequestered in the cytosol. PKCθ is a central molecule for TCR-mediated NF-
κB activation. Phosphorylation of CARMA by PKCθ results in formation of stable CARMA/Bcl10/MALT1 complex and activation of IKK.
Activated IKKβ kinase mediates phosphorylation of IκB molecules and recruitment of SCF
β-TrCP ubiquitin ligase. Activation of alternative
NF-κBpathwayistriggeredbyasubsetofTNFRfamilymembersandismediatedbyNIKandIKKαthatphosphorylatesp100.Theubiquitin-
proteasome pathway is involved in activation of NF-κB via speciﬁc degradation of IκBs and processing of p100 to produce p52.
should be considered as distinct T cell subsets or whether
expression of characteristic molecules is just an adaptation
of already known and well-described Th1, Th2, and Th17
cells to certain microenvironment. This review aims to
discuss the data that will allow us to understand how c-
Rel inﬂuences the development and eﬀector functions of
most important T-cell subsets. Th1 and Th2 cells have
distinct immunological functions by producing their key
cytokines IFN-γ and IL-4, respectively. Recently, IL-17-
producing cells that express transcription factors IRF-4 and
RORγt,namedTh17cells,havebeendescribedtodevelopvia
a unique lineage, independently of the Th1 and Th2 master
transcription factors T-bet and GATA-3 [34–37]. Another
population of CD4+ T cells, so-called follicular helper T
cells (TFH), preferentially reside in germinal centres where
they help B cells to generate high-aﬃne antibodies [38, 39].
Finally, regulatory T (Treg) cells are characterized by their
expression of transcription factor Foxp3 and are essential for
tolerance and prevention of autoimmunity [40, 41].
The transcription factor c-Rel has emerged to be an
important molecule that can mediate proliferation, diﬀer-
entiation, and cytokine production of T cells. However,
the extent and impact of the described defects in c-Rel-
deﬁcient T-cells vary considerably. Experiments with c-Rel-
deﬁcient mice have revealed that this protein is crucial
for optimal IL-2 production and expression of IL-2Rα4 Clinical and Developmental Immunology
(CD25) in T cells [42, 43]. Normally, immature T cells are
unable to produce IL-2. However, once dendritic cells (DCs)
encounter danger signals at the site of infection and get fully
maturated, diﬀerentiation, of na¨ ıve CD4+ T cells is driven
eﬀectively through antigen recognition, cytokine milieu, and
costimulation by CD80 and CD86. In response to antigens, T
cells start producing IL-2 and IL-2/IL2-R-signalling becomes
crucial for their activation and expansion. In light of the
ﬁnding that c-Rel complexes are mainly bound to IκBβ and
that stimulation via CD28 leads to degradation of IκBβ and
activation of c-Rel signalling pathway, it is evident why c-
Rel-deﬁcient T cells cannot respond appropriately to T-cell
activation signals. With regard to activated na¨ ıve T cells,
c-Rel signalling (acting downstream of TCR and CD28)
may also be essential for secretion of other IL-2-dependent
cytokines. IL-2 is known to be required for optimal IL-4
and IFN-γ expression by T-helper cells and for expression
of granzyme and perforin by cytotoxic T lymphocytes (CTL)
[44, 45]. Since c-Rel, AP-1, and NFAT act in concert to reg-
ulate IL-2 expression and T-cell proliferation, IL-2 secretion
is reduced but not completely abrogated in c-Rel-deﬁcient
T cells. Thus, some defects in Th diﬀerentiation observed
under in vitro polarizing conditions in the absence of c-
Rel may indirectly result from decreased T-cell proliferation.
Interestingly, in mature eﬀector T cells that diﬀer from
na¨ ıve ones by producing cytokines more rapidly after TCR
stimulation, IL-2 and IFN-γ gene expression seems to occur
independently of c-Rel-mediated signal transduction [29].
It is likely that regulatory functions of c-Rel on target
gene promotors are accomplished by heterodimerization
with p50 or by forming c-Rel/c-Rel homodimers. There
is also evidence that c-Rel/p50 dimers cooperate with
other NF-κB family members. For example, c-Rel and p65
complexes bind together to IL-2Rα promoter and even
cooperate with other transcription factors such as SRF to
increase expression of IL-2Rα gene [46]. Recently, a c-Rel
binding site was identiﬁed in proximal promoter of Il21 gene
implicatinganimportantroleforc-RelindevelopmentofIL-
21-dependent T and B subsets [47]. IL-21 has been reported
to be essential for both TFH development and regulation of
B-cell function [38, 48–51]. Accordingly, the frequencies of
TFH cells and germinal centre (GC) B cells were signiﬁcantly
reduced in c-Rel-deﬁcient mice immunized with MOG35–55
[47]. We have also found reduced IL-21 production and
GC formation in Peyer’s patches of c-Rel-deﬁcient mice
(A. Visekruna, unpublished data). However, our recent
unpublished results show that, at least in response to IL-
6 stimulation, there was no signiﬁcant diﬀerence between
WT- and c-Rel-deﬁcient CD4+ T cells with respect to IL-
21 production. This suggests that c-Rel might be involved
in IL-6-independent signal transduction pathways leading
to induction of IL-21 expression. Although c-Rel binds to
the promoter of the Il21 gene, many other transcriptional
activators such as STAT-3, IRF-4, and NFATc2 seem to be
more important for optimal Il21 gene expression [52, 53].
More recently, c-Rel has been shown to control the
diﬀerentiation of Treg cells in the thymus by promoting
formation of so-called Foxp3-speciﬁc “enhanceosome [sic]”
containing p65, Smad3, NFATc2, and CREB [54–58]. It has
also become evident that c-Rel protein and RNA expression
are speciﬁcally upregulated in CD4+CD25+ thymocytes
as compared to other T-cell populations in the thymus
indicating the importance of this factor for development
and maintenance of emerging Treg population. Intriguingly,
although c-Rel-deﬁcient mice exhibit diminished Treg cell
numbers, c-Rel appears to be dispensable for immune
suppressive activity of Treg cells, as c-Rel-deﬁcient Treg
cells are able to inhibit T-cell proliferation in vitro and
suppress development of T-cell-induced colitis [58]. Three
highly conserved noncoding DNA sequences (CNSs) in the
Foxp3 locus have been identiﬁed and named CNS1-3. In
silico analysis has revealed that c-Rel complexes but not p65
complexes bind to CNS3 region of Foxp3 locus resembling
the CD28 response element (CD28RE) in the Il2 locus, also
known to be occupied by c-Rel homodimers [59]. Given the
importance of Foxp3 expression in Treg diﬀerentiation and
eﬀector functions, an interesting consideration point is to
better understand how intracellular signalling molecules and
adaptersareinvolvedinNF-κBactivationinTregpopulation.
Although engagement of TCR and IL-2 signalling is crucial
for both thymic and peripheral development of Treg cells,
the overall “quality” of peripheral signals may not mimic all
facets of Treg development in thymus. While TCR signalling
via c-Rel provides an instructive signal to open the Foxp3
locus during thymic development, additional factors are
probably involved in the generation of peripheral Treg
(iTreg) cells. Very recently, we have demonstrated that, in
the presence of TGF-β, the addition of exogenous IL-2 is
suﬃcient to drive iTreg diﬀerentiation and to upregulate
Foxp3 expression in c-Rel-deﬁcient na¨ ıve CD4+ T cells [60].
Further, our unpublished data suggest that in vivo treatment
with immune complexes consisting of IL-2 and anti-IL-2
mAb (JES6-1) leads to a widespread increase in Treg cell
frequencies not only in WT but also in c-Rel deﬁcient mice.
The paradoxical observation that frequencies of Treg cells
increase substantially in c-Rel deﬁcient mice implies that,
at least in the periphery, control of the Foxp3 locus by c-
Rel is not required for maintaining the homeostasis and
expansion of Treg cells. Interestingly, thymic and peripheral
CD4+Foxp3+ Treg cell frequencies are also signiﬁcantly
reduced in mice deﬁcient in upstream components of c-
Rel-activating pathway such as PKC-θ, CARMA1, Bcl10, and
MALT1 [56, 61–63]. It will be of interest to determine if
iTreg cells generated from these mice induce Foxp3 after in
vitro exposure to IL-2 and TGF-β similarly to c-Rel-deﬁcient
T cells. These ﬁndings collectively suggest that c-Rel has an
important nonredundant function for Treg cells by inducing
Foxp3 expression during thymic Treg cell development.
Additionally to its role in several CD4+ T subsets, c-
Rel might play an important role for CD8+ T-cell func-
tion. One mechanism in particular is regulation of IL-2
production as consumption of this cytokine has a crucial
inﬂuence on various aspects of CD8+ T-mediated immunity.
Current experimental data indicate that the PKC-θ/c-Rel-
signallingaxisisacrucialsurvivalpathwayinactivatedCD8+
T lymphocytes. Interestingly, exogenous IL-2 can bypass
survival and proliferative defects in PKC-θ-a n dc - R e l -
deﬁcient CD8+ T cells [64]. Additionally, in the presence ofClinical and Developmental Immunology 5
exogenous IL2, c-Rel-deﬁcient CTL have normal cytotoxicity
in vitro. In vivo studies have shown normal capacity of c-Rel-
deﬁcientCD8+ Tcellstoclearinﬂuenzainfection[65].Major
contribution of c-Rel to functional CTL responses might
comprise regulation of the inﬂammatory environment (e.g.,
regulation of cytokines produced by APC and CD4+ T cells)
rather than playing substantial intrinsic role in cytotoxic T
cells.
4.CrucialRole ofc-Rel inRegulating
Inﬂammation and Immune Defense
againstMicrobialPathogens
In vitro analyses of c-Rel-deﬁcient cells have revealed selec-
tive requirement for c-Rel during IL-12 p40 induction in
macrophages [66]. Similarly, p50/c-Rel dimers have been
described to bind to the proximal promoter of IL-12 p35
and IL-23 p19 subunits in murine macrophages and DC
[67–70]. Both proteins, IL-12 and IL-23, play a crucial
role for the diﬀerentiation of T lymphocytes and immunity
against pathogens. Importantly, maturation of DC is not
aﬀected in the absence of c-Rel, whereas the loss of this
protein in APC compromises DC-mediated CD4+ T-cell
activation [71]. Thus, c-Rel appears to be a crucial link
betweeninnateimmunesignalsandprimaryT-cellresponses
by substantially inﬂuencing a delicate balance between Th1,
Th17, and Treg cells.
Complex in vivo functions of diﬀerent NF-κBf a m i l y
members following exposure to pathogens remain partially
controversial. Infected mice devoid of speciﬁc NF-κBp r o -
teins display distinct phenotypes probably reﬂecting the
ability of individual members to regulate expression of
diﬀerent sets of target genes associated with innate and
adoptive immunity. One of the fundamental immunological
challenges is to understand how the immune system can
decide what type of immune responses to launch against
diﬀerent classes of pathogens. The capacity of Th1 and
Tc1 responses to protect against intracellular pathogens is
well known. For example, the control of infection with
protozoan parasite Leishmania major has been attributed
to IL-12-mediated diﬀerentiation and expansion of CD4+
Th1 cells with subsequent IFN-γ secretion, activation of
infected macrophages, and NO-mediated killing of parasite.
Two studies have shown that mice lacking c-Rel display a
high susceptibility to L. major infection. The reduced levels
of IL-12 p70 in DC as well as defective IFN-γ secretion
b yTc e l l sa n dN Op r o d u c t i o nb ym a c r o p h a g e si nb o t h
L. major-infected MyD88 and c-Rel-deﬁcient mice suggest
that the high susceptibility of such animals is dependent
on TLR-induced activation of c-Rel-signalling pathway with
subsequent development of IL-12-mediated protective Th1
response against Leishmania parasites [72–74]. One might
assume that this mechanism displays a general dependency
of protective Th1 immunity on c-Rel, particularly involving
regulation of IL-12 production by this transcription factor in
APC. Although the failure of c-Rel deﬁcient mice to control
infection with another intracellular parasite Toxoplasma
gondii was also associated with defective Th1 responses,
in contrary to infection with L. major, this eﬀect appears
to be rather dependent on T-cell-intrinsic expression of c-
Rel [75]. Thus, the evidence that c-Rel is essential for the
production of IL-12 in response to LPS and Leishmania,b u t
dispensable for IL-12 production in response to Toxoplasma,
suggests that this transcription factor is associated with
various complex aspects of regulation of innate and adaptive
responses required to control infections [76].
There are emerging insights that c-Rel might play a
key role in inﬂammatory diseases. Recent studies from
several groups have shown that c-Rel is essential for the
development of both colitis as well as experimental autoim-
mune encephalomyelitis (EAE). Impaired Th1 and Th17
development seems to occur in parallel with protection from
EAE in c-Rel-deﬁcient mice [47, 77, 78]. While potentially
multiple roles of c-Rel in the inductive and eﬀector stages
of EAE are still partially elusive, its innate function in the
control of proinﬂammatory responses during an intestinal
inﬂammation is well known [79, 80]. A defect in the
intestinalepithelialbarrierfunctionisanimportantetiologic
factorleadingtodevelopmentofinﬂammatoryboweldisease
(IBD) in humans. After encountering microbial agents,
activation of c-Rel in DC leads to induction of IL-23 and
IL-12 expression. IL-23 strongly enhances production of
IL-17 by previously primed CD4+ T cells and probably
by recently described innate lymphoid cells (ILCs) [81].
The regulation of IL-23 by c-Rel within APC has a critical
role in mediating chronic intestinal inﬂammation. A recent
genetic study in humans and several studies in mice have
uncovered IL-23 as a key factor in the pathogenesis of
Crohn’s disease [82–85]. The role of c-Rel and other NF-κB
family members can be regulated at many diﬀerent levels.
Two very recent studies have provided important clues to
the underlying mechanisms of Th17-cell mediated diseases,
showingthatc-RelisrequiredforRORγtexpressioninTcells
[78, 86]. Therefore, both c-Rel expressed by CD4+ Tc e l l s
regulating directly the expression of a Th17 lineage-speciﬁc
transcription factor RORγt as well as c-Rel expression by
myeloid cells contribute to diﬀerentiation and maintenance
of Th17 cells. Results obtained from mouse models and
human specimens show that, besides c-Rel-mediated Th17
cell diﬀerentiation, IFN-γ-mediated induction of immuno-
proteasomes has an important role for activation of NF-
κB and enhancement of chronic inﬂammation in the gut
[80, 87, 88]. Collectively, induction of inﬂammation in the
gut caused by imbalanced activation of DC expressing high
level of c-Rel and immunoproteasomes contributes to IBD
by augmenting proinﬂammatory Th1 and Th17 responses
(Figure 2). Novel data have also indicated that, in addition
to T cells, ILC might be important factors driving intestinal
inﬂammation in mice and humans [89, 90]. However, the
role of NF-κB transcription factor c-Rel in regulating various
eﬀector functions of these cells has not been characterized
yet.
5. Conclusions andFutureDirections
In last 25 years, major steps forward have been made in
understanding how NF-κB regulates diﬀerent aspects of the6 Clinical and Developmental Immunology
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Figure 2: Induction of immunoproteasomes and c-Rel signalling in APC during intestinal inﬂammation. After disruption of intestinal
barrier, the activation of DC by innate immunity triggers such as TLR ligands results in signalling cascade that induces expression
of immunoproteasomes. The immunoproteasome is highly active form of proteasome that enhances activation of NF-κB signalling.
Additionally, stimulation of TLR releases c-Rel/p50 dimers from IκB to bind to the p40, p35, and p19 promoter. The synergy between
immunoproteasomes and c-Rel leads to an increase of IL-12 and IL-23 secretion by APC contributing directly to T-cell-mediated immune
responses and exacerbation of intestinal inﬂammation.
immune system. Several studies have begun to examine
the role of speciﬁc NF-κB family members in regulating
infections and chronic inﬂammatory disorders. c-Rel has
emerged to play a critical role in inducing inﬂammatory
and immune responses against pathogens by regulating
a crucial set of T-cell stimulatory genes. In addition to
dominant eﬀects of c-Rel on promoting Th1- and Th17-
mediated immune responses, this transcription factor also
plays an important role by providing an initial signal
for opening of the Foxp3 locus in thymic Treg cells.
Although the impact of c-Rel on DC activities to induce
Th2 responses has not been examined extensively, c-Rel-
deﬁcient mice seem to be capable of mounting suﬃcient
Th2 responses. Previous studies suggest that this protein
is not essential for control of Th2-mediated intestinal
inﬂammation following Trichuris muris infection. In con-
trast, NF-κB1- and NF-κB2-deﬁcient mice fail to clear
helminth infections [91]. Such data reﬂect nonoverlapping
functions of individual NF-κB family members suggesting
that targeting speciﬁc NF-κB proteins might be a promis-
ing therapeutic approach in inﬂammation and infectious
diseases. Especially, molecules that speciﬁcally regulate c-
Rel-signalling pathway such as E3 ubiquitin ligase Peli1
might be of particular interests as c-Rel exhibits a unique
dual capacity to regulate both tolerogenic and inﬂammatory
responses.
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